文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

大中性氨基酸转运体LAT1和LAT2的分子与功能鉴定及其在血脑屏障处的药理学意义

Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.

作者信息

Kido Y, Tamai I, Uchino H, Suzuki F, Sai Y, Tsuji A

机构信息

Faculty of Pharmaceutical Sciences, Kanazawa University, Japan.

出版信息

J Pharm Pharmacol. 2001 Apr;53(4):497-503. doi: 10.1211/0022357011775794.


DOI:10.1211/0022357011775794
PMID:11341366
Abstract

We present here the evidence of molecular and functional expression of LAT1 and LAT2, subunits of the large neutral amino acid transporter system L, in cultured brain capillary endothelial cells of the rat. By means of the RT-PCR method, transcripts of LAT1, LAT2 and heavy chain of 4F2 antigen (4F2hc) were detected in rat primary cultured brain capillary endothelial cells (BCECs) and immortalized subline, RBEC1. The uptake properties of RBEC1, such as [3H]leucine and L-[3H]DOPA uptake, were similar to those of primary cultured BCECs. So, RBEC1 may retain almost native properties of the large neutral amino acid uptake activities. [3H]Leucine uptake by RBEC1 showed two saturable components and the Km values of the high- and low-affinity components were 8.92+/-3.18 and 119+/-45 microM, respectively. The Km value of the high-affinity component agreed well with that of LAT1 and the amino acid transport selectivity of RBEC1 was similar to that of LAT1. Therefore, it is suggested that LAT1 is important at the blood-brain barrier of rats. Additionally, the Km value of the low-affinity component was similar to that of LAT2. These observations indicate that LAT1 and LAT2 are involved as transporters for large neutral amino acids at the blood-brain barrier. Additionally, we concluded that RBEC1 is useful as an in-vitro model for evaluation of the pharmacological relevance of system L at the blood-brain barrier.

摘要

我们在此展示大鼠脑毛细血管内皮细胞培养物中大分子中性氨基酸转运系统L的亚基LAT1和LAT2的分子及功能表达证据。通过逆转录聚合酶链反应(RT-PCR)方法,在大鼠原代培养脑毛细血管内皮细胞(BCECs)和永生化亚系RBEC1中检测到LAT1、LAT2和4F2抗原重链(4F2hc)的转录本。RBEC1的摄取特性,如[3H]亮氨酸和L-[3H]多巴摄取,与原代培养的BCECs相似。因此,RBEC1可能保留了大分子中性氨基酸摄取活性的几乎天然特性。RBEC1对[3H]亮氨酸的摄取显示出两个可饱和成分,高亲和力和低亲和力成分的Km值分别为8.92±3.18和119±45 microM。高亲和力成分的Km值与LAT1的Km值吻合良好,且RBEC1的氨基酸转运选择性与LAT1相似。因此,提示LAT1在大鼠血脑屏障中起重要作用。此外,低亲和力成分的Km值与LAT2的Km值相似。这些观察结果表明,LAT1和LAT2作为大分子中性氨基酸的转运体参与血脑屏障的功能。此外,我们得出结论,RBEC1作为一种体外模型,可用于评估系统L在血脑屏障中的药理学相关性。

相似文献

[1]
Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.

J Pharm Pharmacol. 2001-4

[2]
Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).

J Pharm Sci. 2010-5

[3]
The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.

Brain Res. 2000-10-6

[4]
Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies.

Pharm Res. 2000-1

[5]
L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.

Invest Ophthalmol Vis Sci. 2005-7

[6]
Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature.

Neurosci Lett. 2001-6-22

[7]
Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.

J Neurochem. 2001-12

[8]
Expression of a system L neutral amino acid transporter at the blood-brain barrier.

Neuroreport. 2000-11-9

[9]
Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.

Pharm Res. 2018-10-29

[10]
Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.

Anticancer Res. 2006

引用本文的文献

[1]
Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery.

Mol Diagn Ther. 2025-8-22

[2]
Saturation kinetics and specificity of transporters for L-arginine and asymmetric dimethylarginine (ADMA) at the blood-brain and blood-CSF barriers.

PLoS One. 2025-6-11

[3]
Small Molecule Inhibitors of Lymphocyte Perforin as Focused Immunosuppressants for Infection and Autoimmunity.

J Med Chem. 2022-11-10

[4]
Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?

Pharm Res. 2022-7

[5]
Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.

Pharm Res. 2022-7

[6]
Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.

Int J Mol Sci. 2021-9-19

[7]
Prenatal stress-induced disruptions in microbial and host tryptophan metabolism and transport.

Behav Brain Res. 2021-9-24

[8]
The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake.

ChemMedChem. 2021-3-3

[9]
Putative roles of SLC7A5 (LAT1) transporter in pain.

Neurobiol Pain. 2020-6-30

[10]
The Neurovascular Unit: Effects of Brain Insults During the Perinatal Period.

Front Neurosci. 2020-1-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索